|
TW312694B
(cg-RX-API-DMAC10.html)
*
|
1994-09-26 |
1997-08-11 |
Daiichi Seiyaku Co |
|
|
US6169086B1
(en)
|
1997-01-27 |
2001-01-02 |
Daiichi Pharmaceutical Co., Ltd. |
Pyrazole derivatives
|
|
CA2278677A1
(en)
*
|
1997-01-27 |
1998-07-30 |
Daiichi Pharmaceutical Co., Ltd. |
Pyrazole derivatives
|
|
AU2004218260A1
(en)
*
|
2003-01-28 |
2004-09-16 |
Aventis Pharma S.A. |
N-aryl heteroaromatic products, compositions containing same and use thereof
|
|
FR2850379B1
(fr)
*
|
2003-01-28 |
2006-11-17 |
Aventis Pharma Sa |
Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
JP5756457B2
(ja)
*
|
2009-04-06 |
2015-07-29 |
アジオス ファーマシューティカルズ， インコーポレイテッド |
ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
|
|
DK2448581T3
(en)
|
2009-06-29 |
2017-03-13 |
Agios Pharmaceuticals Inc |
Therapeutic compositions and methods for their applications
|
|
PE20120693A1
(es)
|
2009-06-29 |
2012-07-04 |
Agios Pharmaceuticals Inc |
Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
|
|
US9221792B2
(en)
|
2010-12-17 |
2015-12-29 |
Agios Pharmaceuticals, Inc |
N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
|
|
WO2012088314A1
(en)
|
2010-12-21 |
2012-06-28 |
Agios Pharmaceuticals, Inc. |
Bicyclic pkm2 activators
|
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
|
PT3406251T
(pt)
|
2011-05-03 |
2024-01-24 |
Agios Pharmaceuticals Inc |
Ativadores da piruvato-cinase para utilização em terapia
|
|
WO2012151440A1
(en)
|
2011-05-03 |
2012-11-08 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
|
|
WO2014139144A1
(en)
|
2013-03-15 |
2014-09-18 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
|
MX384883B
(es)
|
2015-06-11 |
2025-03-14 |
Agios Pharmaceuticals Inc |
Métodos para usar activadores de piruvato cinasa.
|